Nepedia
Back to Discover
Advanced Reader
🧬

Haemophilia

life science Maturity 11-13 death dying Next article →

This article covers sensitive topics: death_dying. Parents can manage visibility in Parental Controls.

Haemophilia is a genetic disorder that impairs the body's ability to form blood clots. Clotting is a vital process used to stop bleeding after an injury. When a person has haemophilia, they may bleed for a longer duration following an accident. They often experience easy bruising and face increased risks of internal bleeding. This bleeding can occur inside joints or even within the brain.

A woman suffering from Hemophilia
A woman suffering from Hemophilia

To understand how this works, we must look at the intrinsic pathway. This is a specific sequence of steps the blood follows to create a clot. The pathway is necessary when there is damage to the endothelium, which is the lining of a blood vessel. In people with haemophilia, certain clotting factors are missing or low. This prevents the pathway from functioning properly. Without these factors, the body cannot build a stable clot to seal the wound.

There are several distinct types of this condition based on which factor is missing. Haemophilia A is the most common and occurs due to low levels of clotting factor VIII. Haemophilia B occurs because of low levels of clotting factor IX. There is also haemophilia C, which involves low levels of factor XI. Other rare forms include parahaemophilia, caused by low factor V, and Von Willebrand disease.

Factor VIII concentrate in Commercial Packaging
Factor VIII concentrate in Commercial Packaging

The severity of the disorder depends on how much active factor remains in the blood. People with less than 1% active factor are classified as having severe haemophilia. Those with 1% to 5% active factor have moderate haemophilia. People with between 5% and 40% of normal levels have mild haemophilia. Severe cases often involve spontaneous bleeding, which happens without any obvious injury. This can lead to joint bleeds, where blood enters the joint spaces.

Haemophilia is typically an X-linked recessive disorder. This means the genes for clotting factors are located on the X chromosome. Because males have only one X chromosome, a single faulty gene will cause the disease. Females have two X chromosomes, so a healthy gene can often mask a faulty one. This makes females much more likely to be "carriers" rather than being affected themselves. However, a female can be affected if she inherits two faulty X chromosomes.

X-linked recessive (2)
X-linked recessive (2)

History shows how this condition has traveled through generations. In the 1800s, haemophilia B was common among the royal families of Europe.

Erbgang Bluterkrankheit
Erbgang Bluterkrankheit

Scientists made a major breakthrough in 1952 when they determined the difference between haemophilia A and B. Today, we know the specific frequency of these conditions. Haemophilia A affects about 1 in 5,000 to 10,000 males. Haemophilia B affects approximately 1 in 40,000 males at birth.

Medical treatments have changed significantly over time. Doctors treat the condition by replacing the missing clotting factors. These factors can be made from human blood or through recombinant methods.

Factor VIII concentrate in Commercial Packaging
Factor VIII concentrate in Commercial Packaging

Some patients use a medication called desmopressin for mild haemophilia A. Scientists are also conducting clinical trials for gene therapy. This new approach aims to provide a long-term solution by addressing the underlying genetic cause.

Managing the condition is essential to prevent serious complications. Severe joint bleeds can lead to permanent damage or disfigurement through a process called haemarthrosis. This can cause the destruction of cartilage and bone. Internal bleeding in the brain, or intracranial haemorrhage, is a medical emergency. It can cause pressure inside the skull, leading to seizures or loss of consciousness.

Ryan White
Ryan White

Modern medicine helps many people live full lives by managing these risks through regular factor replacement.

572 words

Where will your curiosity go next?

Keep exploring at your chosen reading level.

🖼️ Images & Media (5)
File:A woman suffering from Hemophilia.png
A woman suffering from Hemophilia.png
File:X-linked recessive (2).svg
X-linked recessive (2).svg
File:Factor VIII concentrate in Commercial Packaging.JPG
Factor VIII concentrate in Commercial...
File:Erbgang Bluterkrankheit.svg
Erbgang Bluterkrankheit.svg
File:Ryan White.jpg
Ryan White.jpg
More to explore

🔬 Go deeper

More advanced topics to explore

🪜 Step back

Simpler topics to build understanding

What is Nepedia?

A free, ad-free encyclopedia for children. Every article is written at five reading levels, so the same page works for a five-year-old and a fifteen-year-old — use the level switcher above to see this one change. No account needed to read.